A private business has helped supercharge a controversial federal drug program. Patients and insurers have been left with big bills.
Related Posts
Mr. Musk Goes to Washington — With a $2 Trillion Agenda
Donald Trump tapped the tech mogul to co-lead an effort to slash government spending, but questions abound over how such an initiative would actually work.
His Start-Up May Not Survive Chaotic Rollout of Trump’s Tariffs
A sourdough baker turned entrepreneur in North Carolina has delayed his new product as he contemplates the prospect that higher costs will doom his company.
China’s Exports to Africa Are Soaring as Trade to U.S. Plunges
Already this year, China’s trade surplus with Africa is nearly as big as all of 2024, a sign of how President Trump’s tariffs are reshaping […]